Speciality Medicines Stock Price Analysis and Quick Research Report. Is Speciality Medicines an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Speciality Medicines. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Speciality Medicines has a PE ratio of 15.1001745271946 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Speciality Medicines has ROA of 27.4964% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Speciality Medicines has a Current ratio of 5.3566.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Speciality Medicines has a ROE of 37.8545%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Speciality Medicines has a Debt to Equity ratio of 0.1659 which means that the company has low proportion of debt in its capital.

• Sales growth: Speciality Medicines has reported revenue growth of 111.7051% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Speciality Medicines for the current financial year is 15.667377135267%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Speciality Medicines is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Speciality Medicines is Rs 9.7979. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Speciality Medicines in Ticker for free. Also, one can get the intrinsic value of Speciality Medicines by using Valuation Calculators, which are available with a Finology ONE subscription. 

Speciality Medicines FAQs

Q1. What is Speciality Medicines share price today?
Ans: The current share price of Speciality Medicines is Rs 147.95.

Q2. What is the market capitalisation of Speciality Medicines?
Ans: Speciality Medicines has a market capitalisation of Rs 129.98585182 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Speciality Medicines?
Ans: The PE ratio of Speciality Medicines is 15.1001745271946 and the P/B ratio of Speciality Medicines is 2.18256222035691, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Speciality Medicines share?
Ans: The 52-week high share price of Speciality Medicines is Rs 140.95, and the 52-week low share price of Speciality Medicines is Rs 121.1.

Q5. Does Speciality Medicines pay dividends?
Ans: Currently, Speciality Medicines does not pay dividends. Dividend yield of Speciality Medicines is around 0%.

Q6. What are the face value and book value of Speciality Medicines shares?
Ans: The face value of Speciality Medicines shares is Rs 10, while the book value per share of Speciality Medicines is around Rs 67.7873. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Speciality Medicines?
Ans: Speciality Medicines has a total debt of Rs 5.0468 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Speciality Medicines?
Ans: The ROE of Speciality Medicines is 37.8545% and ROCE of Speciality Medicines is 34.4674%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Speciality Medicines a good buy for the long term?
Ans: The Speciality Medicines long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Speciality Medicines undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Speciality Medicines appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Speciality Medicines’s financials?
Ans: You can review Speciality Medicines’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.